×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [11]
内容类型
期刊论文 [11]
发表日期
2022 [5]
2021 [4]
2020 [1]
2012 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
限定条件
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:
He, Libin
;
Shen, Xiabo
;
Liu, Yiyuan
;
Gao, Lu
;
Wu, Jiayi
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/23
Advanced human epidermal growth factor receptor 2-positive breast cancer (advanced HER2-positive breast cancer)
apatinib
case report
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:
Wu, Xiaofan
;
Yang, Hongjian
;
Yu, Xingfei
;
Qin, Jiang-Jiang
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/22
HER2
breast cancer
targeted therapy
drug resistance
overcoming strategies
Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022, 卷号: 11
作者:
Zhang, Yanqiang
;
Xu, Xiaoqing
;
Hu, Can
;
Du, Yian
;
Ding, Guangyu
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
Gastric cancer
HER2-positive
conversion therapy
Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Fang, Zi-Ru
;
Shen, Xia-Bo
;
Wu, Jia-Yi
;
Chen, Ke-Yu
;
Shao, Xi-Ying
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2022/12/23
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
收藏
  |  
浏览/下载:92/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
期刊论文
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:
Yang, ZiYan
;
Wang, Wei
;
Wang, Xiaojia
;
Qin, ZhiQuan
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/01/10
cardiotoxicity
ErbB2
targeting drugs
breast cancer
therapy
Pulmonary enteric adenocarcinoma
期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:
Gong, Jiali
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2021/11/01
PEAC
Immunohistochemistry
Mutation analysis
Diagnosis
Prognosis
Properties and gene expression profiling of acquired radioresistance in mouse breast cancer cells
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Qin, Feng
;
Fan, Qiang
;
Yu, Peter K. N.
;
Almahi, Waleed Abdelbagi
;
Kong, Peizhong
收藏
  |  
浏览/下载:95/0
  |  
提交时间:2021/06/15
Breast cancer
acquired radioresistance
gene expression profiling
energy metabolism
Exploring the concepts and practices of advanced breast cancer treatment: a narrative review
期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9
作者:
Wang, Xiaojia
;
Shao, Xiying
;
Huang, Jian
;
Lei, Lei
;
Huang, Yuan
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2021/06/15
Metastatic breast cancer (MBC)
treatment
cure
molecular types
targeted therapy
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Yang, Zi-yan
;
Huang, Jia-huan
;
Chen, Bo
;
Xu, Chun-wei
;
Lei, Lei
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2020/11/30
salivary duct carcinoma
tyrosine kinase inhibitor
pyrotinib
HER2 positive
targeted
©版权所有 ©2017 CSpace - Powered by
CSpace